SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-140412
Filing Date
2021-04-29
Accepted
2021-04-29 16:09:54
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A d169676ddefa14a.htm DEFA14A 30302
2 GRAPHIC g169676gra004.jpg GRAPHIC 908
3 GRAPHIC g169676gra02.jpg GRAPHIC 18229
4 GRAPHIC g169676pmt002.jpg GRAPHIC 41186
  Complete submission text file 0001193125-21-140412.txt   104066
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-39527 | Film No.: 21870618
SIC: 2834 Pharmaceutical Preparations